Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Korro Bio Inc (KRRO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Korro Bio's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
58.240 +0.020    +0.03%
03/05 - Closed. Currency in USD ( Disclaimer )
After Hours
60.000
+1.760
+3.022%
17:30:09 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 15,521
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 56.330 - 59.250
Korro Bio 58.240 +0.020 +0.03%

Korro Bio Inc Company Profile

 
Get an in-depth profile of Korro Bio Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

102

Equity Type

ORD

Korro Bio, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases primarily in the United States. Its lead product candidate is KRRO-110 which is in preclinical trials for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). It uses its RNA editing platform, OPERA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson’s disease, Amyotrophic lateral sclerosis, severe alcohol-associated hepatitis, and other subsets of pain. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Contact Information

Address One Kendall Square Building 600-700
Suite 6-401 Cambridge, 02139
United States
Phone 617 468 1999
Fax -

Top Executives

Name Age Since Title
Timothy R. Pearson 56 2023 Independent Director
David L. Lucchino 55 - Director
Ram Aiyar 46 2020 CEO, President & Director
Rachel Meyers 60 2023 Independent Director
Nessan Bermingham 51 - Co-Founder & Independent Chairman of the Board
Ali Behbahani 48 - Independent Director
Jean-Francois Formela 67 - Co-Founder & Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

KRRO Comments

Write your thoughts about Korro Bio Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Nicholas Chan
Nicholas Chan Feb 13, 2023 9:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They should have stopped and change the research direction long ago when it was already quite clear that the research is going no where. The fact that they made excuses last time and continue on burning money on this futile research caused this complete failure today. The CEO of the company is to be blamed.
Nicholas Chan
Nicholas Chan Feb 13, 2023 8:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
dropping 80% after hours. this is total KO.
Hotdog Circus
Hotdogcircus Dec 30, 2022 2:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
😎👍
Nhat Doan
Nhat Doan Dec 30, 2022 10:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
TEST CAN NOT SHORT MUST NOT BUY 🔊📢👹
Nicholas Chan
Nicholas Chan Nov 11, 2022 10:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This is a trash stock. Falling from 50 to 2, yet still no signs of giving any meaningful rally at all. dump this share!
Saleh AlSaad
Saleh AlSaad May 26, 2022 10:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
We think the price during may should be 3 - 4 USD as fear price per share
Saleh AlSaad
Saleh AlSaad May 26, 2022 10:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The company hold cash on hand with 124 million USD which make big chance for succeeding in short future
Saleh AlSaad
Saleh AlSaad May 26, 2022 10:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The rank price during 2023 as suggest per share 10 USD, We believe the price during 2023 will be between 15 - 20 USD Per share
Saleh AlSaad
Saleh AlSaad May 26, 2022 8:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Zacks rank 2.44 USD per share, I think the rank price per share 5 USD Per share
Ante Parcina
Ante Parcina May 22, 2022 12:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
May will be month of FREQ!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email